Abstract:Human C5a anaphylatoxin is a potent bioactive molecule that possesses both spasmogenic and leukocyte-related properties. As such, it normally serves as a local mediator of the acute inflammatory response. Additionally, C5a, through its actions of mononuclear phagocytes, may act to bridge the gap in the acute-chronic inflammatory continuum. While these properties are critical to normal host defense mechanisms, it is now apparent that this anaphylatoxin and/or its des-Arg74 derivative, may exert significant systemic effects that are manifest as cardiopulmonary abnormalities and intravascular activation of granulocytes. Knowledge of these properties is critically important for understanding the clinical sequelae exhibited by patients undergoing extracorporeal circulation since we now know that both hemodialysis and cardiopulmonary bypass [28-30] procedures promote intravascular complement activation and C5a formation. Viewed in this context, it seems reasonable to postulate that many of the immediate and delayed responses to extracorporeal circulation might be mediated by C5a formed in the extracorporeal circuit (table IV). For example, it is now recognized that a few particularly susceptible patients display adverse reactions during the initial phases of hemodialysis. The symptoms of this so-called 'first-use syndrome' may range from severe urticaria and angioedema to life-threatening bronchospasm, hypotension, and cardiopulmonary collapse. Some investigators have presented data which suggest that complement-derived products may be causative of these symptoms in some patients [31]. While this hypothesis remains to be confirmed, present evidence clearly demonstrates that C5a alone may produce many of the observed phenomena. In addition to the acute effects produced by C5a, both our own basic studies and the clinical investigations presented by others at this conference suggest that the long-term effects of repeated C5a exposure in the dialyzed patient may be considerable. Thus, there has been a great deal of interest in the role of complement-derived mediators as initiators of leukocyte degranulation and toxic oxygen radical production and an exploration of the significance of these events in the eventual development of chronic pulmonary fibrosis in the dialyzed patient. Similarly, the effects of repeated exposure to IL-1 that has been postulated to occur as a result of C5a triggering of monocytes during dialysis is currently an active area of investigation.(ABSTRACT TRUNCATED AT 400 WORDS)

The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses.

Revealing the signaling of complement receptors C3aR and C5aR1 by anaphylatoxins

Illumination of the complement receptors C3aR and C5aR signaling by anaphylatoxins

Recent Progress in Capturing and Neutralizing Inflammatory Cytokines

Functional Modulation of Human Monocytes Derived DCs by Anaphylatoxins C3a and C5a.

Complement C5a Regulates IL‐17 by Affecting the Crosstalk Between DC and Γδ T Cells in CLP‐induced Sepsis

Decoding anaphylatoxins: unveiling the molecular mechanisms of complement receptor activation and signaling

Species-Specific Differences In Regulation Of Macrophage Inflammation By The C3a-C3a Receptor Axis

The Properties of Human C5a Anaphylatoxin

Molecular basis of anaphylatoxin binding, activation, and signaling bias at complement receptors

Role of C5a-C5aR axis in the development of atherosclerosis

C3‐dependent effector functions of complement

New Insights for C5a and C5a Receptors in Sepsis.

The complement C3a and C5a signaling in renal diseases: a bridge between acute and chronic inflammation

The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity

Expression and Regulation of Complement Receptors by Human Natural Killer Cells.

Cyclic AMP Plays a Critical Role in C3a-receptor Mediated Regulation of Dendritic Cells in Antigen Uptake and T Cell Stimulation

The Roles of CCR9/CCL25 in Inflammation and Inflammation-Associated Diseases

Progress in Study on Complement Component 5

Mechanism of activation and biased signaling in complement receptor C5aR1

C5L2 is no longer an orphan receptor——progress and prospect